Skip to main content
. 2021 Jun 18:1–5. doi: 10.1017/dmp.2021.208

Table 1.

Patient characteristics and details

Characteristic Total (n = 140) Survivors (n = 88) Nonsurvivors (n = 52) P-value*
Age (years) 56.8 ± 15.4 54.1 ± 15.2 61.3 ± 15.0 0.007
Gender (males) 97 (69.2%) 61 (69.3%) 36 (69.2%) 0.991
Pre-existing comorbidities 94 (67.1%) 58 (65.9%) 36 (69.2%) 0.686
Place of inhabitation (other state) 54 (38.5%) 31 (35.2%) 23 (44.2%) 0.290
Symptom onset to hospitalization (days) 5 [3-7] 5 [3-9] 5 [3-7] 0.572
Dyspnea 121 (86.4%) 76 (86.4%) 45 (86.5%) 0.977
Fever 111 (79.3%) 71 (80.7%) 40 (76.9%) 0.596
Cough 87 (62.1%) 58 (65.9%) 29 (55.8%) 0.232
Weakness 13 (9.3%) 8 (9.1%) 5 (9.6%) 1.000
Myalgia 4 (2.9%) 4 (4.5%) 0 (0%) 0.297
Other symptoms 34 (24.2%) 20 (22.7%) 14 (26.9%) 0.576
Duration of ICU stay 14 [9-21] 17 [11-23] 8 [6-18] 0.000
Duration of hospital stay 17 [10-24] 19 [13-28] 10 [6-18] 0.000
Referred from other facility 69 (49.3%) 42 (47.7%) 27 (51.9%) 0.631
ICU mortality 52 (37.1%)
FiO2 0.8 ± 0.1 0.7 ± 0.2 0.8 ± 0.1 0.006
Systolic blood pressure (mmHg) 125 ± 16
128 [117-132]
125 ± 14 126 ± 19 0.664
Diastolic blood pressure (mmHg) 78 ± 11
79 [70-86]
78 ± 10 78 ± 12 0.736
Respiratory rate (per min) 23 ± 6
(12-40)
23 ± 6 25 ± 6 0.040
Heart rate (per min) 91 [85-100]
(56-140)
91 ± 13 98 ± 15 0.009
Glasgow Coma Scale score 15 [15-15]
(5-15)
15 ± 0 14 ± 2 0.001
Total leucocyte count (/mm3) 10282 [7000-12500] 10428 [6700-13000] 10034 [7325-12050] 0.620

Note: Values are mean ± SD or median [IQR] or number of patients (%).

*

Comparison between survivors and nonsurvivors.